Related Articles
Identification of microRNAs involved in gefitinib resistance of non‑small‑cell lung cancer through the insulin‑like growth factor receptor 1 signaling pathway
Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line
Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway
Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells